We are live on ! Find out more
NVCR icon

NovoCure
NVCR

104 hedge funds and large institutions have $746M invested in NovoCure in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

414% more call options, than puts

Call options by funds: $24.4M | Put options by funds: $4.75M

222% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 9

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

31% more capital invested

Capital invested by funds: $567M → $746M (+$178M)

22% more funds holding

Funds holding: 85 → 104 (+19)

5% more ownership

Funds ownership: 37.2% → 42.2% (+5%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
104
Holders Change
+19
Holders Change %
+22.35%
% of All Funds
2.59%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
29
Increased
37
Reduced
24
Closed
9
Calls
$24.4M
Puts
$4.75M
Net Calls
+$19.7M
Net Calls Change
+$3.68M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.9M
2
AC
Ascend Capital
California
+$12.9M
3
LCM
Laurion Capital Management
New York
+$10.9M
4
Norges Bank
Norges Bank
Norway
+$8.83M
5
CM
Castleark Management
Illinois
+$8.81M

Top Sellers

Rank Fund Capital Flow
1
RPAM
Rhenman & Partners Asset Management
Sweden
-$10.8M
2
HCM
Highline Capital Management
New York
-$4.36M
3
PCM
Peregrine Capital Management
Minnesota
-$4.3M
4
SG
StepStone Group
California
-$3.93M
5
TA
Tamarack Advisers
California
-$3.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$4.15M +$4.08M +207,591 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.03M +$53.5K +2,724 +1%
GPP
28
Great Point Partners
Connecticut
$3.53M +$3.49M +177,666 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.42M +$198K +10,086 +6%
Citadel Advisors
30
Citadel Advisors
Florida
$3.4M +$2.28M +116,261 +211%
Invesco
31
Invesco
Georgia
$3.35M +$3.32M +168,700 New
TCIM
32
TIAA CREF Investment Management
New York
$3.02M -$63.5K -3,231 -2%
AR
33
Advisory Research
Illinois
$2.21M +$594K +30,241 +37%
TA
34
Teachers Advisors
New York
$2.08M +$5.21K +265 +0.3%
CEP
35
Chicago Equity Partners
Illinois
$2.02M +$729K +37,110 +57%
Charles Schwab
36
Charles Schwab
California
$1.93M – – –
ARTA
37
A.R.T. Advisors
New York
$1.91M +$627K +31,900 +49%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.84M -$193K -9,840 -10%
RGI
39
River Global Investors
United Kingdom
$1.78M -$748K -38,069 -30%
Stifel Financial
40
Stifel Financial
Missouri
$1.78M +$1.76M +89,466 New
EIM
41
Essex Investment Management
Massachusetts
$1.64M +$1.62M +82,484 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.53M +$25.6K +1,300 +2%
CCM
43
Courage Capital Management
Tennessee
$1.49M -$1.47M -75,000 -50%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.46M +$62.9K +3,200 +5%
CS
45
Credit Suisse
Switzerland
$1.32M +$590K +30,017 +82%
NI
46
Numeric Investors
Massachusetts
$1.32M +$1.3M +66,317 New
Wells Fargo
47
Wells Fargo
California
$1.31M +$402K +20,439 +45%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$1.3M +$11.1K +565 +0.9%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$1.23M – – –
Ameriprise
50
Ameriprise
Minnesota
$1.16M +$1.15M +58,610 New
1
2
3 4 5

NVCR Hedge Fund Activity: Q3 2017 in Review

104 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q3 2017, worth a combined $746M — up 31% from $567M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new NVCR positions and 9 closed out — a net gain of 20 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $17.9M. The largest seller was Rhenman & Partners Asset Management, cutting an estimated $10.8M.

  • 104 institutional investors held NovoCure (NVCR) as of Q3 2017, up from 85 in Q2 2017.
  • Funds reported $746M of NovoCure stock for Q3 2017, up 31% quarter-over-quarter.
  • 29 funds opened new NovoCure positions in Q3 2017 and 9 closed out, a net change of +20 holders.
  • The largest NovoCure buyer in Q3 2017 was Fidelity Investments, an estimated $17.9M added.
  • The largest NovoCure seller in Q3 2017 was Rhenman & Partners Asset Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2017.